Cosyntropin Injection 0.25 MG 1mL 10 VL

Cosyntropin 0.25 mg/mL Injectable Solution (1 mL vial, 10-vial package) is a synthetic adrenocorticotropic hormone (ACTH) used as a diagnostic agent to evaluate adrenal cortical function. When administered as part of an ACTH stimulation test, cosyntropin stimulates the adrenal cortex to produce cortisol, allowing assessment of adrenal responsiveness and hypothalamic-pituitary-adrenal (HPA) axis activity.

This formulation is commonly used in clinical and laboratory settings to support evaluation of adrenal insufficiency and related endocrine conditions. Cortisol levels are typically measured before and after administration to assess hormonal response and guide diagnostic interpretation.

Administration should follow established clinical protocols, including precise dosing and timed sample collection to ensure accurate results. Cosyntropin is generally well tolerated when used as directed, though monitoring during and after administration is recommended to identify any potential adverse reactions or hypersensitivity.

Store vials according to labeled requirements to maintain stability and effectiveness. Refer to manufacturer-provided documentation for complete information regarding preparation, administration, precautions, and safety considerations.